A human-cell recombinant prethrombin-2 platform producing thrombin with enhanced fibrinogen processing for in vitro applications

The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation

10.1016/s0021-9258(18)83649-3 · doi-reference

Factor XIII: A Coagulation Factor With Multiple Plasmatic and Cellular Functions

10.1152/physrev.00016.2010 · doi-reference

Surface-dependent reactions of the vitamin K-dependent enzyme complexes

10.1182/blood.v76.1.1.1 · doi-reference

Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality

10.1182/blood.v77.12.2637.2637 · doi-reference

Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin

10.1016/s0021-9258(17)44663-1 · doi-reference

International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders

10.1111/ijlh.14201 · doi-reference

The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions

10.1016/0167-4838(83)90272-8 · doi-reference

Study of the specificity of thrombin with tripeptidyl-p-nitroanilide substrates

10.1111/j.1432-1033.1981.tb06229.x · doi-reference

Evidence that human α-thrombin is a monovalent cation-activated enzyme

10.1016/0003-9861(80)90406-3 · doi-reference

Structure-based design of novel potent nonpeptide thrombin inhibitors

10.1021/jm0109513 · doi-reference

Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-(arginyl)]-2-piperidinecarboxylic acid

10.1021/bi00296a014 · doi-reference

Kinetic study of the inhibition of the amidolytic activity of thrombin by benzamidine and N-dansyl-(p-guanidino)-phenylalanine-piperidide (I-2581)

10.1016/0020-711x(87)90313-2 · doi-reference

Inhibition of bovine and human thrombins by derivatives of benzamidine

10.1016/0049-3848(84)90302-5 · doi-reference

The non-Michaelian action of thrombin on peptide p-nitroanilide substrates

10.1042/bj2430329 · doi-reference

Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH)

10.1016/0049-3848(77)90208-0 · doi-reference

Thermal shift assay to probe melting of thrombin, fibrinogen, fibrin monomer, and fibrin: Gly-pro-Arg-pro induces a fibrin monomer-like state in fibrinogen

10.1016/j.bbagen.2020.129805 · doi-reference

Thermofluor-based high-throughput stability optimization of proteins for structural studies

10.1016/j.ab.2006.07.027 · doi-reference

Structural characterization of a thrombin-aptamer complex by high resolution native top-down mass spectrometry

10.1007/s13361-017-1751-7 · doi-reference

Recombinant production, purification, crystallization, and structure analysis of human transforming growth factor β2 in a new conformation

10.1038/s41598-019-44943-4 · doi-reference

Recombinant production of human α2-macroglobulin variants and interaction studies with recombinant G-related α2-macroglobulin binding protein and latent transforming growth factor-β2

10.1038/s41598-019-45712-z · doi-reference

Updated transient gene expression protocol in Expi293F cells using PEI

10.3389/fbioe.2025.1661193 · doi-reference

10.1007/978-1-0716-1859-2_18

10.1007/978-1-0716-1859-2_18 · doi-reference

Effect of prothrombin Belgrade mutation, causing antithrombin resistance, on fibrin clot properties

10.1111/ijlh.14195 · doi-reference

Mapping the prothrombin-binding site of pseutarin C by site-directed PEGylation

10.1182/blood.2021014878 · doi-reference

Disruption of the kringle 1 domain of prothrombin leads to late onset mortality in zebrafish

10.1038/s41598-020-60840-7 · doi-reference

MASP-1 induced clotting — the first model of prothrombin activation by MASP-1

10.1371/journal.pone.0144633 · doi-reference

Thrombosis from a prothrombin mutation conveying antithrombin resistance

10.1056/nejmoa1201994 · doi-reference

Binding of substrate in two conformations to human prothrombinase drives consecutive cleavage at two sites in prothrombin

10.1074/jbc.m410866200 · doi-reference

High-yield preparation of recombinant human α-thrombin for therapeutic use

10.1016/j.jbiosc.2015.02.001 · doi-reference

Crystal structure of prothrombin reveals conformational flexibility and mechanism of activation

10.1074/jbc.m113.466946 · doi-reference

Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin

10.1006/prep.1997.0733 · doi-reference

Identification of residues linked to the slow → fast transition of thrombin

10.1073/pnas.92.24.11185 · doi-reference

Functional mapping of the surface residues of human thrombin

10.1074/jbc.270.28.16854 · doi-reference

Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A)

10.1016/s0021-9258(19)78135-6 · doi-reference

Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues

10.1016/s0021-9258(18)92771-7 · doi-reference

Expression of completely γ-carboxylated recombinant human prothrombin

10.1016/s0021-9258(18)48304-4 · doi-reference

Co-expressing turnip crinkle virus-coat protein with the serine protease α-thrombin precursor (pFIIa) in Nicotiana benthamiana Domin

10.1007/s11627-018-09956-0 · doi-reference

Cloning, expression and functional characterization of autoactivated human prethrombin-2 synthetic gene by using Pichia pastoris SMD1168 as a host

10.5454/mi.10.2.1 · doi-reference

Direct cloning, expression and purification of human activated thrombin in prokaryotic system and CD analysis report of produced thrombin: molecular characterization of recombinant thrombin

10.1007/s10989-020-10046-2 · doi-reference

Temperature effect on expression of recombinant human prethrombin-2 in Escherichia coli BL21 (DE3) ArcticExpress

10.24114/jpkim.v11i3.15779 · doi-reference